跳至主要内容
临床试验/ISRCTN80334919
ISRCTN80334919已完成未知

Double Blind Randomised Placebo Controlled Trial of Oral Co-trimoxazole in Pulmonary Fibrosis

The Peel Trust Fund (UK)0 个研究点目标入组 20 人开始时间: 2005年9月9日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Male or female below 85 years old
  • 2. Demonstrated breathlessness with oxygen desaturation below 90% on two baseline shuttle walking tests (SWT)
  • 3. Physical examination, HRCT scan and pulmonary function test results compatible with IPF (with or without histological diagnosis)
  • 4. New diagnosis of IPF without treatment or previous diagnosis on regular daily prednisolone
  • 5. Symptoms of exertional dyspnoea affecting life quality
  • 6. Normal glucose 6-phosphate dehydrogenase levels to avoid drug induced haemolysis. Normal vitamin B12 levels

排除标准

  • 1. Recognised secondary causes of pulmonary fibrosis
  • 2. Co-trimoxazole allergy or severe upper GI symptoms
  • 3. Abnormal liver function tests or concurrent drug treatments that disturb liver function including azathioprine
  • 4. Inability to perform the shuttle test due to musculoskeletal or cardiac causes

研究者

发起方
The Peel Trust Fund (UK)

相似试验